États-Unis · Bourse & Finance · The Wall Street Journal

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

Publié par The Wall Street Journal · États-Unis il y a 11 h

The venture arm of diabetes research nonprofit Breakthrough T1D was ramping up its efforts to raise $150 million to propel new treatments to market when its leadership collapsed…

Lire l'article complet sur The Wall Street Journal Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.wsj.com)

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

À lire aussi

Thursday’s Economic Calendar

Trump’s New Tariffs Get a Familiar Day in Court

CFTC seeks to define event contracts as swaps amid prediction market fight

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem

How a Top Diabetes Nonprofit Reined In Its Venture-Capital Arm

Partager

À lire aussi

Thursday’s Economic Calendar

Trump’s New Tariffs Get a Familiar Day in Court

CFTC seeks to define event contracts as swaps amid prediction market fight

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem